Impact of tumor microenvironment on adoptive T cell transfer activity.

No abstract is available for this paper.

• Publication year

  2022

• Venue

  International Review of Cell and Molecular Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/bs.ircmb.2022.03.002PMID 35798502
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting tumor-associated macrophages to synergize tumor immunotherapy

  2021cited by this paper
• Neutrophil Extracellular Traps (NETs) in Cancer Invasion, Evasion and Metastasis

  2021cited by this paper
• Key chemokines direct migration of immune cells in solid tumors

  2021cited by this paper
• Human Hyaluronidase PH20 Potentiates the Antitumor Activities of Mesothelin-Specific CAR-T Cells Against Gastric Cancer

  2021cited by this paper
• Hypoxia-inducible factor activity promotes antitumor effector function and tissue residency by CD8+ T cells.

  2021cited by this paper
• Stromal hyaluronan accumulation is associated with low immune response and poor prognosis in pancreatic cancer

  2021cited by this paper
• Searching for Peptide Inhibitors of T Regulatory Cell Activity by Targeting Specific Domains of FOXP3 Transcription Factor

  2021cited by this paper
• Inhibition of arginase modulates T-cell response in the tumor microenvironment of lung carcinoma

  2021cited by this paper
• IL8, Neutrophils, and NETs in a Collusion against Cancer Immunity and Immunotherapy

  2020cited by this paper
• Hold on or Cut? Integrin- and MMP-Mediated Cell–Matrix Interactions in the Tumor Microenvironment

  2020cited by this paper
• Metabolic support of tumor-infiltrating regulatory T cells by lactic acid

  2020cited by this paper
• Efficacy and Safety of CAR-Modified T Cell Therapy in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Prospective Clinical Trials

  2020cited by this paper
• CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor Escape

  2020cited by this paper
• Accumulation of long-chain fatty acids in the tumor microenvironment drives dysfunction in intrapancreatic CD8+ T cells

  2020cited by this paper
• Lactate Limits T Cell Proliferation via the NAD(H) Redox State

  2020cited by this paper
• BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial

  2020cited by this paper
• The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy

  2020cited by this paper
• HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-PD-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment

  2020cited by this paper
• Glucose Metabolism on Tumor Plasticity, Diagnosis, and Treatment

  2020cited by this paper
• Future of immune checkpoint inhibitors: focus on tumor immune microenvironment

  2020cited by this paper
• Dynamic Imaging of LDH Inhibition in Tumors Reveals Rapid In Vivo Metabolic Rewiring and Vulnerability to Combination Therapy

  2020cited by this paper
• A framework for advancing our understanding of cancer-associated fibroblasts

  2020cited by this paper
• Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans

  2020cited by this paper
• CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth

  2020cited by this paper
• Fat and Furious: Lipid Metabolism in Antitumoral Therapy Response and Resistance.

  2020cited by this paper
• Cancer-Associated Fibroblast Mediated Inhibition of CD8+ Cytotoxic T Cell Accumulation in Tumours: Mechanisms and Therapeutic Opportunities

  2020cited by this paper
• TLR 7/8 agonist reverses oxaliplatin resistance in colorectal cancer via directing the myeloid-derived suppressor cells to tumoricidal M1-macrophages.

  2020cited by this paper
• Cancer SLC43A2 alters T cell methionine metabolism and histone methylation

  2020cited by this paper
• Lipid Metabolism and Resistance to Anticancer Treatment

  2020cited by this paper
• Antitumor Effects of CAR T Cells Redirected to the EDB Splice Variant of Fibronectin

  2020cited by this paper
• Reprogramming of fatty acid metabolism in cancer

  2019cited by this paper
• WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers

  2019cited by this paper
• TEM8/ANTXR1-specific CAR T cells mediate toxicity in vivo

  2019cited by this paper
• Collagenase Nanoparticles Enhance the Penetration of Drugs Into Pancreatic Tumors.

  2019cited by this paper
• Context Drives Diversification of Monocytes and Neutrophils in Orchestrating the Tumor Microenvironment

  2019cited by this paper
• New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments

  2019cited by this paper
• Inflammation and Cancer: Triggers, Mechanisms, and Consequences.

  2019cited by this paper
• Recent Findings in the Regulation of Programmed Death Ligand 1 Expression

  2019cited by this paper
• The Tumor Metabolic Microenvironment: Lessons from Lactate.

  2019cited by this paper
• Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial

  2019cited by this paper
• The CD14+HLA-DRlo/neg Monocyte: An Immunosuppressive Phenotype That Restrains Responses to Cancer Immunotherapy

  2019cited by this paper
• Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?

  2019cited by this paper
• CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies

  2019cited by this paper
• HIF-1α Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma

  2019cited by this paper
• Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer

  2019cited by this paper
• Nanobody-based CAR T cells that target the tumor microenvironment inhibit the growth of solid tumors in immunocompetent mice

  2019cited by this paper
• T cell engineered with a novel nanobody‐based chimeric antigen receptor against VEGFR2 as a candidate for tumor immunotherapy

  2019cited by this paper
• Neutrophils escort circulating tumour cells to enable cell cycle progression

  2019cited by this paper
• Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity

  2019cited by this paper
• CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas

  2019cited by this paper
• Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor.

  2019cited by this paper
• Preventing Lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted Hosts

  2018cited by this paper
• Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies

  2018cited by this paper
• Cancer‐related circulating and tumor‐associated neutrophils – subtypes, sources and function

  2018cited by this paper
• Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability

  2018cited by this paper
• STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells

  2018cited by this paper
• Fatty acid metabolism complements glycolysis in the selective regulatory T cell expansion during tumor growth

  2018cited by this paper
• Defining the role of the tumor vasculature in antitumor immunity and immunotherapy

  2018cited by this paper
• Metformin-Induced Reduction of CD39 and CD73 Blocks Myeloid-Derived Suppressor Cell Activity in Patients with Ovarian Cancer.

  2018cited by this paper
• TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer.

  2018cited by this paper
• Effects of the potassium‐sparing diuretic amiloride on chemotherapy response in canine osteosarcoma cells

  2018cited by this paper
• Host STING-dependent MDSC mobilization drives extrinsic radiation resistance

  2017cited by this paper
• Culturing CTLs under Hypoxic Conditions Enhances Their Cytolysis and Improves Their Anti-tumor Function.

  2017cited by this paper
• Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments.

  2017cited by this paper
• Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma.

  2017cited by this paper
• Tumor-associated fibrosis as a regulator of tumor immunity and response to immunotherapy

  2017cited by this paper
• Targeting hepatic macrophages to treat liver diseases.

  2017cited by this paper
• An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression

  2017cited by this paper
• Interferon-inducible CXC-chemokines are crucial immune modulators and survival predictors in colorectal cancer

  2017cited by this paper
• Chemotherapeutic agent-mediated elimination of myeloid-derived suppressor cells

  2017cited by this paper
• Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor Immunity by Facilitating CD8+ T Cell Migration into Tumors

  2016cited by this paper
• Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases

  2016cited by this paper
• The Sulfamate Small Molecule CAIX Inhibitor S4 Modulates Doxorubicin Efficacy

  2016cited by this paper
• Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche.

  2016cited by this paper
• Ccl22 Diverts T Regulatory Cells and Controls the Growth of Melanoma.

  2016cited by this paper
• The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction.

  2016cited by this paper
• LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells.

  2016cited by this paper
• Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability.

  2016cited by this paper
• Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy.

  2016cited by this paper
• Mast cells as targets for immunotherapy of solid tumors.

  2015cited by this paper
• Enhancement of adoptive T cell transfer with single low dose pretreatment of doxorubicin or paclitaxel in mice

  2015cited by this paper
• Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity

  2015cited by this paper
• IL17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis

  2015cited by this paper
• CXCR4 inhibition in tumor microenvironment facilitates anti‐programmed death receptor‐1 immunotherapy in sorafenib‐treated hepatocellular carcinoma in mice

  2015cited by this paper
• Targeting the tumor vasculature to enhance T cell activity

  2015cited by this paper
• The Great Escape; the Hallmarks of Resistance to Antiangiogenic Therapy

  2015cited by this paper
• Non-redundant Requirement for CXCR3 Signaling during Tumoricidal T Cell Trafficking across Tumor Vascular Checkpoints

  2015cited by this paper
• Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T

  2015cited by this paper
• Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.

  2015cited by this paper
• T cell exclusion, immune privilege, and the tumor microenvironment

  2015cited by this paper
• Mast Cells as Regulators of T Cell Responses

  2015cited by this paper
• Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients

  2015cited by this paper
• Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction

  2015cited by this paper
• Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses.

  2015cited by this paper
• The Role of Stroma in Tumor Development.

  2015cited by this paper
• Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR Stimulation

  2015cited by this paper
• Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice.

  2014cited by this paper
• Endothelial cell-derived interleukin-6 regulates tumor growth

  2014cited by this paper
• Glucose Metabolism Regulates T Cell Activation, Differentiation, and Functions

  2014cited by this paper
• Lysyl oxidase in cancer research.

  2014cited by this paper

• Ultrasound-mediated targeted micro/nanobubbles: breaking new boundaries in precision tumor therapy.

  2026cites this paper
• Exploring CAR-PBMCs: A Novel Strategy Against EGFR-Positive Tumor Cells

  2025cites this paper
• Genetic Engineering in CAR T Cells for Solid Tumors: Current State, Barriers and Future Developments

  2025cites this paper
• Mechanisms of resistance to adoptive cell therapy with tumor-infiltrating lymphocytes

  2025cites this paper
• Challenges and new technologies in adoptive cell therapy

  2023cites this paper
• How does TCR-T cell therapy exhibit a superior anti-tumor efficacy.

  2023cites this paper
• Type I interferon and cancer

  2023cites this paper
• Nanomaterials: Breaking through the bottleneck of tumor immunotherapy.

  2023cites this paper
• Nanomaterials in tumor immunotherapy: new strategies and challenges

  2023cites this paper
• CAR T Cell Therapy: Remedies of Current Challenges in Design, Injection, Infiltration and Working

  2023cites this paper
• Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8+ T cells eradicates peritoneal metastases in mouse models

  2022cites this paper